Skip to main content
Clinical Trials/NCT05943015
NCT05943015
Completed
Not Applicable

Comparison of Postoperative Analgesic Efficacy of Quadratus Lumborum II, Quadratus Lumborum III and Paravertebral Blocks in Elective Laparoscopic Cholecystectomies

Gaziosmanpasa Research and Education Hospital1 site in 1 country122 target enrollmentSeptember 5, 2022

Overview

Phase
Not Applicable
Intervention
Quadratus Lumborum Block II
Conditions
Postoperative Pain
Sponsor
Gaziosmanpasa Research and Education Hospital
Enrollment
122
Locations
1
Primary Endpoint
Total amount of tramadol use
Status
Completed
Last Updated
9 months ago

Overview

Brief Summary

This trial is a prospective, randomized, single-center, single blinded-analysis trial, the objective of which is compare the postoperative analgesia efficacy of Quadratus lumborum II, Quadratus Lumborum III and Paravertebral blocks in elective laparoscopic cholecystectomy.

Detailed Description

Laparoscopic approach in cholecystectomy surgery is frequently preferred because of its advantages in systemic complications, morbidity, mortality and hospital stay. Pain is one of the important causes of late discharge after surgery. Laparoscopic cholecystectomy surgery requires a multimodal analgesia approach because of its multiple pain components.Regional analgesia techniques are effective in reducing the side effects such as intraoperative opioid use, postoperative pain and nausea and vomiting. Quadratus lumborum block and paravertebral plane blocks are regional techniques performed for multimodal analgesia. The aim of this study is to determine an effective analgesia method by comparing the postoperative analgesic effectiveness of Quadratus Lumborum II, Quadratus Lumborum III and Paravertebral blocks in elective laparoscopic cholecystectomy surgery.

Registry
clinicaltrials.gov
Start Date
September 5, 2022
End Date
December 15, 2024
Last Updated
9 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18-65 years, American Society of Anesthesiologists physical statusⅠ-II

Exclusion Criteria

  • local anesthetic allergy
  • Infection at the procedure site
  • Body Mass Index \>35 kg/m2
  • Anticoagulant use with bleeding disorder
  • Chronic analgesia and opioid use
  • with mental and psychiatric disorders

Arms & Interventions

Quadratus Lumborum Block II

Quadratus Lumborum Block II

Intervention: Quadratus Lumborum Block II

Quadratus Lumborum Block II

Quadratus Lumborum Block II

Intervention: Patient controlled intravenous analgesia

Quadratus Lumborum Block III

Quadratus Lumborum Block III

Intervention: Quadratus Lumborum Block III

Quadratus Lumborum Block III

Quadratus Lumborum Block III

Intervention: Patient controlled intravenous analgesia

Paravertebral Block

Paravertebral Block

Intervention: Paravertebral Block

Paravertebral Block

Paravertebral Block

Intervention: Patient controlled intravenous analgesia

Outcomes

Primary Outcomes

Total amount of tramadol use

Time Frame: within 24 hours after the surgery

The total tramadol use of the patients in 24 hours will be recorded.

Secondary Outcomes

  • postoperative length of hospital stay(within 1 weeks after the surgery)
  • Block onset time(30 min after the block)
  • intraoperative remifentanil consumption(during operation procedure)
  • Visual Analogue Scale values at 1st, 6th, 12th and 24th hours(at 1st, 6th, 12th and 24th hours after the surgery)
  • side effects such as nausea, vomiting and shoulder pain(within 24 hours after the surgery)

Study Sites (1)

Loading locations...

Similar Trials